CBER
Medical abbreviation · Medical Research
| Stands for | Center for Biologics Evaluation and Research |
|---|---|
| Categories | Medical |
CBER stands for Center for Biologics Evaluation and Research, a medical research abbreviation.
FDA center that regulates vaccines, blood and blood products, cellular and gene therapies, tissues and allergenic products. It reviews clinical trials and approvals for these products and monitors their safety.
Example: CBER approved the CAR-T therapy for a new lymphoma indication.
Usage notes
CBER co-manages the Vaccine Adverse Event Reporting System with the CDC. Its Office of Therapeutic Products reviews cell and gene therapies, a rapidly growing area. Pronounced "SEE-ber".
Related abbreviations
More medical research abbreviations
- 510(k) – Premarket notification (FDA section 510(k))
- AHRQ – Agency for Healthcare Research and Quality
- ARR – Absolute risk reduction
- AUC – Area under the receiver operating characteristic curve
- BTD – Breakthrough therapy designation
- CDER – Center for Drug Evaluation and Research
- CEA – Cost-effectiveness analysis
- CI – Confidence interval
- CITI – Collaborative Institutional Training Initiative
- COI – Conflict of interest
- CONSORT – Consolidated Standards of Reporting Trials
- CPG – Clinical practice guideline
See all 94 medical research abbreviations →
This entry is for general education and is not medical advice. Abbreviation use varies between institutions; always confirm in context.